Results for tag: "Targeted Protein Degradation"

The Targeted Protein Degradation market is a subset of the biopharmaceuticals industry, focused on the development of drugs that can selectively target and degrade specific proteins in the body. This approach has the potential to treat diseases that are caused by the overproduction of certain proteins, such as cancer, autoimmune diseases, and metabolic disorders. Targeted protein degradation drugs are designed to be more specific and less toxic than traditional drugs, and can be used to target proteins that are difficult to target with traditional drugs. The Targeted Protein Degradation market is a rapidly growing field, with many companies investing in research and development. Companies in the market include Arvinas, C4 Therapeutics, CStone Pharmaceuticals, and Proteostasis Therapeutics. Show Less Read more